Kevin Robert Lind - Nov 13, 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CEO, Director
Signature
/s/ Andrew J. Cronauer, Attorney-In-Fact
Stock symbol
LBPH
Transactions as of
Nov 13, 2024
Transactions value $
$40,002
Form type
4
Date filed
11/13/2024, 08:48 PM
Previous filing
Oct 29, 2024
Next filing
Dec 2, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LBPH Common Stock Options Exercise $40K +12.8K +2.97% $3.12 444K Nov 13, 2024 Direct F1
transaction LBPH Common Stock Gift $0 -80K -18.03% $0.00 364K Nov 13, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Options Exercise $0 -12.8K -4.78% $0.00 255K Nov 13, 2024 Common Stock 12.8K $3.12 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a cash exercise of vested stock options without a subsequent sale of the underlying shares of common stock.
F2 Represents shares of common stock gifted to a donor-advised trust.
F3 The shares subject to the stock option vested and became exercisable in 24 equal monthly installments commencing November 27, 2022.